Shire Viropharma decision won’t cause FTC to 'pull punches,' official says
A federal appeals court decision in the US Federal Trade Commission's case against Shire Viropharma does not “handcuff” the agency's ability to seek relief from more recent or ongoing violations of...To view the full article, register now.
Already a subscriber? Click here to view full article